Skip to main content
. 2021 Mar 6;13(5):1129. doi: 10.3390/cancers13051129

Table 2.

Performance indicators for FIT and colonoscopy and outcomes of colorectal cancer screening program in Lithuania between 2014 and 2018.

Variable 2014 2015 2016 2017 2018
Target population 1,297,155 1,311,156 1,325,082 1,336,298 1,346,670
FIT results
Number of FIT negative persons (% of all test) 217,659 188,529 211,424 210,137 222,394
(92.67) (89.76) (90.28) (91.63) (92.07)
Number of FIT positive persons (% of all test) 17,222 21,507 22,761 19,207 19,159
(7.33) (10.24) (9.72) (8.37) (7.93)
Compliance to colonoscopy (% of FIT positive) 8382 12,630 12,916 12,112 11,140
(48.7) (58.7) (56.8) (63.1) (58.2)
Colonoscopy with sedation (% of all colonoscopies) 5304 7993 9575 8907 8557
(63.3) (63.3) (74.1) (73.5) (75.1)
Colonoscopy without sedation (% of all colonoscopies) 3078 4637 3341 3205 2583
(36.7) (36.7) (25.9) (26.5) (24.9)
Number of patients with biopsies performed 3029 4519 4717 4316 3499
Number of patients with detected adenoma 1584 2564 2895 2601 2163
Adenoma detection rate (% of biopsies) 18.9 20.3 22.41 21.47 19.42
Proportion of adenoma of test-positive persons (%) 9.20 11.92 12.72 13.54 11.29
Proportion of adenoma of screened persons (%) 0.67 1.22 1.24 1.13 0.90
Number of persons with detected CRC 221 248 217 227 178
Positive predictive value for CRC 7.30 5.49 4.60 5.26 5.09
% CRC of test-positive 1.28 1.15 0.95 1.18 0.93
% CRC of screened persons 0.09 0.12 0.09 0.10 0.07

CRC—colorectal cancer; FIT—fecal immunochemical test.